These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 17919499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC.
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
    Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ.
    Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
    [Abstract] [Full Text] [Related]

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO, Beales IL.
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S, Hu MC, Cella C, Piscione T, Filmus J, Rosenblum ND.
    Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H, Naito J, Inoue Y, Sowa H, Sugimoto T, Chihara K.
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression and function of bone morphogenetic proteins in the development of the embryonic endocardial cushions.
    Keyes WM, Logan C, Parker E, Sanders EJ.
    Anat Embryol (Berl); 2003 Sep; 207(2):135-47. PubMed ID: 12905017
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.